Skip navigation
Paperback | $30.00 Short | £20.95 | ISBN: 9780262517935 | 144 pp. | 6 x 9 in | 1 b&w illus| September 2012
 

Biomedical Consulting Agreements

A Guide for Academics

Overview

"The book is exceptionally to the point—and useful.  I’ve recommended it to our senior staff for themselves and for the faculty they deal with.  Despite the title limiting it to “Biomedical”, I found it more widely applicable.  The examples are all “biomedical”, but the rest is not limited."
-Lita Nelsen, Director, Technology Licensing Office, Massachusetts Institute of Technology

 

There can be a clash of cultures when academic scientists negotiate consulting agreements with biotechnology or pharmaceutical companies. Scientists, accustomed to the collegial atmosphere of the laboratory and sometimes disdainful of legal paperwork, might be less than diligent in reading the fine print. On the other hand, a company--motivated to protect discoveries and trade secrets--might write provisions that are favorable to its interests, leaving it to the scientist to raise objections or offer a counterproposal. The scientist, meanwhile, might believe that it would be impolite or antagonistic to raise questions about a company’s agreement.

This book offers an essential guide for academic scientists and physicians who are considering consulting work in the field of biomedicine. In it, the authors--an attorney and a Nobel Laureate in Medicine, both with extensive experience reviewing and negotiating consulting agreements--outline key issues to consider before signing a consulting agreement. These issues range from the obvious--intellectual property, confidentiality, and fees--to those that might not spring immediately to mind, including indemnity, different classes of stock, and the relevance of insider trading and securities laws.

About the Authors

Edward Klees is General Counsel at the University of Virginia Investment Management Company and was formerly Associate General Counsel of the Howard Hughes Medical Institute.

H. Robert Horvitz, 2002 Nobel Laureate in Physiology or Medicine, is Professor in the Department of Biology and a member of the McGovern Institute for Brain Research and of the Koch Institute for Integrative Cancer Research at MIT and an Investigator at the Howard Hughes Medical Institute.

Table of Contents

  • Biomedical Consulting Agreements
  • Biomedical Consulting Agreements
  • A Guide for Academics
  • Edward Klees and H. Robert Horvitz
  • The MIT Press
  • Cambridge, Massachusetts
  • London, England
  • ©
  • 2012
  • Edward Klees and H. Robert Horvitz
  • All rights reserved. No part of this book may be reproduced in any form by any electronic or mechanical means (including photocopying, recording, or information storage and retrieval) without permission in writing from the publisher.
  • MIT Press books may be purchased at special quantity discounts for business or sales promotional use. For information, please email special_sales@mitpress.mit.edu or write to Special Sales Department, The MIT Press, 55 Hayward Street, Cambridge, MA 02142.
  • This book was set in Syntax and Times Roman by Toppan Best-set Premedia Limited, Hong Kong. Printed and bound in the United States of America.
  • Library of Congress Cataloging-in-Publication Data
  • Klees, Edward, 1959–
  • Biomedical consulting agreements : a guide for academics / Edward Klees and H. Robert Horvitz.
  •  p. cm.
  • Includes bibliographical references and index.
  • ISBN 978-0-262-51793-5 (pbk. : alk; paper)
  • 1. Medicine—Research—law and legislation—United States. 2. Medical consultants—Legal status, laws, etc.—United States. 3. Consulting contracts—United States.  4. Universities and colleges—United States.—Faculty—Handbooks, manuals, etc.  I. Horvitz, H. Robert. II. Title.
  • KF3821.K54 2012
  • 344.7303′1172–dc23
  • 2012013234
  • 10 9 8 7 6 5 4 3 2 1
  • E.K. dedicates this book to Susan, Jessica, and Rachel.
  • H.R.H. dedicates this book to the memory of his father Oscar Horvitz, to his mother Mary Horvitz, and to Martha, Alex, Joe, and Chris.
  • Contents
  • Acknowledgments xi
  • Disclaimer xiii
  • 1 Introduction 1
  • 2 Issues to Consider when Negotiating a Consulting Agreement 7
  • A. Define What You Want in the Contract
  • 8
  • B. The Contract Is a Legal Agreement—Make Sure It Is Right
  • 8
  • 1. Read the Contract
  • 8
  • 2. The Words Mean What They Say
  • 9
  • 3. If Something Is Unclear, It Might Be Wrong—or Wrongly Interpreted Later
  • 10
  • 4. Legalisms
  • 11
  • 5. If It Is Not in the Contract, You Might Not Get It
  • 11
  • C. Do Not Assume You Have to Sign a Contract as Is
  • 12
  • D. Protect All Intellectual Property
  • 12
  • E. Review University Policies
  • 13
  • 1. Time Commitment
  • 14
  • 2. Disclosure of Laboratory Results
  • 14
  • 3. Use of University Resources
  • 14
  • 4. Involvement of Postdoctoral Researchers and Students
  • 14
  • 5. Conduct of Research
  • 14
  • 6. “Significant Financial Interest”
  • 15
  • 7. Employment by Company
  • 15
  • 8. Multiple Relationships with Company
  • 15
  • 9. Use of Name or University Letterhead
  • 15
  • 10. Consulting during a Sabbatical
  • 16
  • 3 What Constitutes Consulting?
  • 17
  • A. Service on an Advisory Board
  • 18
  • B. Conduct of Research
  • 18
  • C. Meetings with Investors
  • 19
  • D. Serving as a Company Director or Officer
  • 20
  • E. Advising Venture Capital Funds
  • 21
  • F. “Expert Network” and Hedge Fund Consulting
  • 22
  • G. Expert Witness Services—Litigation
  • 23
  • H. Company Seminars, Speeches, Symposia—CDAs
  • 24
  • I. A Note about CDAs Linked to Consulting Agreements
  • 26
  • J. A Final Word Concerning Chapter 3
  • 27
  • 4 Scope of Services
  • 29
  • 5 Cash Compensation
  • 31
  • A. Retainer
  • 31
  • B. Consulting Fee
  • 32
  • C. Travel Time
  • 33
  • D. Expenses
  • 33
  • E. Taxes on Retainers and Consulting Fees
  • 34
  • F. Deferral of Compensation Income through Retirement Savings
  • 34
  • 6 Shares, Stock Options, and Taxes
  • 35
  • A. Shares and Options Generally
  • 35
  • B. Vesting
  • 42
  • C. Acceleration Events
  • 43
  • D. Antidilution Rights
  • 45
  • E. Registration Rights
  • 46
  • F. Some Thoughts about Taxes
  • 47
  • 1. Introduction: Caveats
  • 47
  • 2. Overview
  • 47
  • 3. Tax Risks
  • 50
  • 4. Ordinary Income (Loss) versus Capital Gain (Loss)
  • 52
  • 5. Section 83(b) Election for Restricted Stock
  • 52
  • 6. Gifts and Estate Planning
  • 57
  • G. Fair Market Value
  • 58
  • H. Royalty Interest
  • 58
  • I. Interest in a VC Firm
  • 58
  • J. Liquidation Preferences and Participating and Nonparticipating Preferred Stock
  • 59
  • K. Conclusion
  • 62
  • 7 Confidentiality Obligations
  • 65
  • A. Confidential Information in Your Possession
  • 65
  • B. Company Confidential Information
  • 67
  • 1. Obligation to Keep Confidential
  • 67
  • 2. Definition of Confidential Information
  • 68
  • 3. Exceptions to the Definition of Confidential Information
  • 70
  • 4. Access to Your Manuscripts
  • 71
  • 8 IP Rights
  • 73
  • A. Ownership Rights
  • 74
  • B. “No Infringement” Covenant
  • 76
  • C. “Works for Hire” and “Moral Rights”
  • 76
  • D. Power of Attorney
  • 78
  • E. List of Existing Inventions
  • 78
  • 9 Noncompetition
  • 81
  • 10 Time Commitment
  • 83
  • 11 Term and Termination
  • 85
  • 12 Multiple Relationships with One Company
  • 87
  • 13 Start-Up Issues
  • 89
  • 14 Other Clauses
  • 91
  • A. Indemnity
  • 91
  • B. Governing Law; Legal Remedies
  • 94
  • C. Use of Consultant’s Name
  • 96
  • D. Consulting for Affiliated Companies; Assignment
  • 97
  • E. Survival
  • 99
  • F. Independent Contractors
  • 100
  • G. Representations and Warranties—Your Guarantees
  • 100
  • 15 Use of Consulting Entity
  • 103
  • 16 Conclusion
  • 105
  • Attachment A: Basic Consulting Agreement
  • 107
  • Glossary
  • 113
  • Notes
  • 117
  • Index
  • 121

Endorsements

"In this valuable guide, lawyer Edward Klees and Nobel-prizing winning researcher H. Robert Horvitz draw on their decades of experience with academic-industry interactions to provide a crisp introduction to key issues, including conflict of interest, confidentiality, intellectual property, and compensation. Written in clear and accessible prose, and with a very practical outlook, it is a must-read for any academic contemplating entering into a consulting arrangement."
Marc Tessier-Lavigne, President, The Rockefeller University

"Biomedical Consulting Agreements is the book I wish had been available when starting my first company. It concisely walks the consultant through all the important topics from elementary to advanced, with real-life examples of how the relationship can go well or awry. Even though I have been through more consultancies than I can quickly count, I learned an enormous amount from this book."
Roger Y. Tsien, Department of Chemistry and Biochemistry, University of California, San Diego; Nobel Laureate in Chemistry, 2008

"I loved this book and am sure that all potential consultants in the biomedical field will find it enlightening. The many examples sprinkled throughout give life to the legal concepts and will help researchers understand the ramifications of contract words and their actions. The book is jargon-free, and I highly recommend it for anyone who is interested in working as a consultant. Our office will definitely make several copies of this superb reference book available for our university researchers."
Katharine Ku, Director, Office of Technology Licensing, Stanford University

"Consulting agreements between academic scientists and corporations not only protect discoveries and intellectual property, but also deal with risks related to securities laws, such as insider trading. Giving advice requires an in depth understanding of these issues and the different cultures of academicians versus corporate lawyers. Edward Klees and Robert Horvitz have applied the same degree of rigor that characterizes the best academic research to understanding the principles and subtleties of these agreements. They provide a clear description of critical issues that are understood by surprisingly few, e.g., liquidation preferences and participation rights of preferred stock. This section alone makes Biomedical Consulting Agreements worthwhile reading for any academic scientist with an interest in the corporate world."
Ansbert K. Gadicke, Managing Director, MPM Capital

The book is exceptionally to the point—and useful.  I’ve recommended it to our senior staff for themselves and for the faculty they deal with.  Despite the title limiting it to “Biomedical”, I found it more widely applicable.  The examples are all “biomedical”, but the rest is not limited.

Lita Nelsen, Director, Technology Licensing Office, Massachusetts Institute of Technology